Acorda Therapeutics
ACOR
#11268
Rank
NZ$1.46 M
Marketcap
NZ$1.18
Share price
0.00%
Change (1 day)
-95.60%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -NZ$0.44 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2023 the company made an earning of -NZ$0.48 Billion a decrease over its 2022 earnings that were of -NZ$9.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.44 Billion-8.57%
2023 -NZ$0.48 Billion4848.63%
2022 -NZ$9.55 Million-93.25%
2021 -NZ$0.15 Billion2.52%
2020 -NZ$0.14 Billion-69.45%
2019 -NZ$0.46 Billion-700.62%
2018 NZ$75.12 M-118.02%
2017 -NZ$0.42 Billion805.99%
2016 -NZ$46.03 Million-173.88%
2015 NZ$62.29 M-6.58%
2014 NZ$66.68 M20.19%
2013 NZ$55.48 M18.7%
2012 NZ$46.74 M-26.54%
2011 NZ$63.62 M
2009 -NZ$0.15 Billion10.65%
2008 -NZ$0.14 Billion86.17%
2007 -NZ$70.54 Million68.1%
2006 -NZ$41.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$54.85 M-111.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-NZ$0.14 Billion-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
NZ$78.07 M-116.07%๐Ÿ‡บ๐Ÿ‡ธ USA